TIDMVENN

Venn Life Sciences Holdings PLC

02 April 2015

Venn Life Sciences Holdings Plc

("Venn" or the "Company" or the "Group")

Investor teach-in

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, will be hosting a teach-in where Tony Richardson, CEO will provide an overview and strategy of the Company on Tuesday 21 April 2015. No new material trading or financial information will be disclosed.

The event is open to all investors and analysts and will be held from 16:30 until 19:30 in the Black Bar at Rocket Bar, 6 Adams Court, Old Broad Street, London, EC2N 1DX and will be followed by drinks and canapés.

To register for the event, please email venn@walbrookpr.com or call the Walbrook PR team below.

Enquiries:

 
Venn Life Sciences Holdings Plc                                  www.vennlifesciences.com 
Tony Richardson, Chief Executive Officer                             Tel: +353 154 99 341 
Orla Mc Guinness, Marketing Manager                                 Tel: +33 676 93 11 78 
Zeus Capital (Nominated Adviser and 
 Broker) 
Ross Andrews/Andrew Jones                                              Tel: 0161 831 1512 
Alex Davies                                                            Tel: 020 7533 7727 
 
Walbrook PR Ltd                           Tel: +44 (0)20 7933 8780 or venn@walbrookpr.com 
Paul McManus                                                     Mob: +44 (0)7980 541 893 
Lianne Cawthorne                                                 Mob: +44 (0)7584 391 303

About Venn Life Sciences Limited:

Venn Life Sciences is a Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn recently established an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAFLLFBEZFEBBX

Hvivo (LSE:HVO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hvivo Charts.
Hvivo (LSE:HVO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hvivo Charts.